Qiagen NV at Cowen Healthcare Conference (Virtual) Transcript
All right. Good morning, and good afternoon, everybody. It's our pleasure to welcome Thierry Bernard from QIAGEN to the Cowen Conference. On the line, we also have from Investor Relations, Phoebe Loh and John Galardi. Thanks to all of you for being here. So Thierry brings extensive experience in molecular diagnostics, commercial operations, and international business to QIAGEN, prior to QIAGEN, as many of you know, he worked for bioMérieux for 15 years and led various business functions and units there.
So thank you for being here today. Always a pleasure to catch up with you about all things, diagnostics and all things, QIAGEN. We have an ambitious agenda to get through over the next half hour. I think, Thierry, just correct me if I'm wrong, did you want to make some opening remarks before we got into it? Or do you want me to just start throwing some questions at you?
I think we can go
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
